GENTILE, GABRIELLA
GENTILE, GABRIELLA
DIPARTIMENTO DI MEDICINA SPERIMENTALE
1901P Impact of radiotherapy timing on immune checkpoint inhibitors efficacy in metastatic non-small cell lung cancer
2025 Siringo, M.; Gentile, G.; Sabatini, A.; Larocca, F.; Spagnuolo, A.; Tramontano, E.; Magri, V.; Bulzonetti, N.; Gelibter, A. J.
20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment
2025 Gentile, G.; Gerosa, R.; De Azambuja, E.; Piccart-Gebhart, M.
Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature
2024 Gentile, Gabriella; Scagnoli, Simone; Arecco, Luca; Santini, Daniele; Botticelli, Andrea; Lambertini, Matteo
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis
2026 Arecco, L.; Cacilhas, P. M.; Bobato Lara Gismondi, C.; Bruzzone, M.; Gentile, G.; Gerosa, R.; Blondeaux, E.; Agostinetto, E.; Dauccia, C.; Lobo-Martins, S.; Grochot, R.; Saini, K. S.; Azim, H. A.; Debiasi, M.; De Caluwe, A.; Buisseret, L.; Del Mastro, L.; Lambertini, M.; De Azambuja, E.
Beyond the BRCA1/2 genes in ovarian cancer: the role of germline pathogenic variants in the ATM gene
2025 # 1, Daniele Guadagnolo; # 2, Angelo Minucci; 3, Antonella Chiavassa; Gentile, Gabriella; 3, Francesca Salvatori; 1, Nader Khaleghi Hashemian; 2, Giulia Maneri; 4 5, Maria Piane; 6, Simona Grotta; 6, Paola Grammatico; 1, Antonio Pizzuti; 3 7, Daniele Santini; De Marchis, Laura
Clinical characteristics and drug–drug interactions in human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab deruxtecan: real-world data from the DE-REAL study
2026 Pisegna, S.; Scagnoli, S.; Gentile, G.; Chiavassa, A.; Caputo, R.; De Laurentiis, M.; Curigliano, G.; Lambertini, M.; Pantano, F.; Orlandi, A.; Palazzo, A.; Paris, I.; Vernieri, C.; Tedesco, B.; Giampaglia, M.; Palleschi, M.; Ballatore, Z.; Alesini, D.; D'Auria, G.; Fabbri, M. A.; Rossi, L.; Fiscon, G.; Marchetti, P.; Fabi, A.; Botticelli, A.
Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC. Report of two cases
2024 Siringo, M; Larocca, F; Spagnuolo, A; Gentile, G; Anile, M; Diso, D; Santini, D; Gelibter, A
Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study
2023 Siringo, Marco; Gentile, Gabriella; Caponnetto, Salvatore; Sperduti, Isabella; Santini, Daniele; Cortesi, Enrico; Gelibter, ALAIN JONATHAN
FBXW7 Gene Mutation and Expression in Colorectal Cancer (CRC): A Systematic Review from Molecular Mechanisms to Clinical Translation
2025 Arrivi, Giulia; Gentile, Gabriella; Roberto, Michela; Delle Cave, Donatella
Fertility preservation in young patients with breast cancer: insights from the Gemme Dormienti network
2025 Gentile, Gabriella; Tesei, Cristiano; Brunetti, Stefania; Cavaceppi, Paola; Sorrenti, Giuseppe; Lambertini, Matteo; Ciccarone, Mariavita
Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies
2025 Arecco, Luca; De Moura Leite, Luciana; Gentile, Gabriella; Jankovic, Kristina; Stana, Mihaela; Ottonello, Silvia; Scavone, Graziana; Spinaci, Stefano; Lambertini, Matteo
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives
2025 Arecco, Luca; Gentile, Gabriella; Gerosa, Riccardo; Lambertini, Matteo; Buisseret, Laurence; De Caluwé, Alex; De Azambuja, Evandro
Management of fertility preservation in young female patients with gastrointestinal cancer: A case series and systematic literature review
2025 Gentile, Gabriella; Ciccarone, Mariavita
Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge
2025 Gerosa, R.; Gentile, G.; Arecco, L.; Dauccia, C.; Nannini, S.; Lobo-Martins, S.; Agostinetto, E.; Lambertini, M.; Santoro, A.; Aftimos, P.; Piccart-Gebhart, M.; De Azambuja., E.
Out-of-pocket costs burden for cancer treatment toxicities and symptoms management in Italy: A prospective, multicenter pilot study
2023 Giusti, Raffaele; Filetti, Marco; Lombardi, Pasquale; Gentile, Gabriella; Toccaceli, Paolo; Fumi, Guglielmo; Vacca, Denise; Colpani, Emilia; Ravoni, Giulio; Daniele, Gennaro; Porzio, Giampiero
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis
2023 Arecco, L; Blondeaux, E; Bruzzone, M; M Latocca, M; Mariamidze, E; Begijanashvili, S; Sokolovic, E; Gentile, G; Scavone, G; Ottonello, S; Boutros, A; Vaz-Luis, I; Saura, C; A Anderson, R; Demeestere, I; A Azim Jr, H; de Azambuja, E; A Peccatori, F; Del Mastro, L; H Partridge, A; Lambertini, M
Selective Internal Radiation Therapy (SIRT): a new emerging role for Breast Cancer Liver Metastases
2023 Gentile, G; Salvatori, F; Siringo, M; Cianni, R; Bagni, O; Caponnetto, S; Cortesi, E
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a sub-analysis of the APHINITY trial
2026 Agostinetto, Elisa; Gentile, Gabriella; Samy, Faye; Di Cosimo, Serena; Aftimos, Philippe; Pondé, Noam; Eiger, Daniel; Lambertini, Matteo; Cameron, David; Kiermaier, Astrid; Bailey, Andrew; Viale, Giuseppe; Loi, Sherene; Piccart, Martine; De Azambuja, Evandro
The efficacy of preoperative low-residue diet on postoperative ileus following cesarean section
2023 Palaia, I.; Caruso, G.; Perniola, G.; Di Donato, V.; Brunelli, R.; Vestri, A.; Scudo, M.; Gentile, G.; Musella, A.; Benedetti Panici, P.; Muzii, L.
The financial toll of cancer: uncovering the links between financial toxicity and symptom burden
2025 Filetti, Marco; Lombardi, Pasquale; Gentile, Gabriella; Toccaceli, Paolo; Fumi, Guglielmo; Vacca, Denise; Colpani, Emilia; Ravoni, Giulio; Mazzuca, Federica; Daniele, Gennaro; Porzio, Giampiero; Bruera, Eduardo; Giusti, Raffaele
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1901P Impact of radiotherapy timing on immune checkpoint inhibitors efficacy in metastatic non-small cell lung cancer | 2025 | Siringo, M.; Gentile, G.; Sabatini, A.; Larocca, F.; Spagnuolo, A.; Tramontano, E.; Magri, V.; Bulzonetti, N.; Gelibter, A. J. | |
| 20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment | 2025 | Gentile, G.; Gerosa, R.; De Azambuja, E.; Piccart-Gebhart, M. | |
| Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature | 2024 | Gentile, Gabriella; Scagnoli, Simone; Arecco, Luca; Santini, Daniele; Botticelli, Andrea; Lambertini, Matteo | |
| Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis | 2026 | Arecco, L.; Cacilhas, P. M.; Bobato Lara Gismondi, C.; Bruzzone, M.; Gentile, G.; Gerosa, R.; Blondeaux, E.; Agostinetto, E.; Dauccia, C.; Lobo-Martins, S.; Grochot, R.; Saini, K. S.; Azim, H. A.; Debiasi, M.; De Caluwe, A.; Buisseret, L.; Del Mastro, L.; Lambertini, M.; De Azambuja, E. | |
| Beyond the BRCA1/2 genes in ovarian cancer: the role of germline pathogenic variants in the ATM gene | 2025 | # 1, Daniele Guadagnolo; # 2, Angelo Minucci; 3, Antonella Chiavassa; Gentile, Gabriella; 3, Francesca Salvatori; 1, Nader Khaleghi Hashemian; 2, Giulia Maneri; 4 5, Maria Piane; 6, Simona Grotta; 6, Paola Grammatico; 1, Antonio Pizzuti; 3 7, Daniele Santini; De Marchis, Laura | |
| Clinical characteristics and drug–drug interactions in human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab deruxtecan: real-world data from the DE-REAL study | 2026 | Pisegna, S.; Scagnoli, S.; Gentile, G.; Chiavassa, A.; Caputo, R.; De Laurentiis, M.; Curigliano, G.; Lambertini, M.; Pantano, F.; Orlandi, A.; Palazzo, A.; Paris, I.; Vernieri, C.; Tedesco, B.; Giampaglia, M.; Palleschi, M.; Ballatore, Z.; Alesini, D.; D'Auria, G.; Fabbri, M. A.; Rossi, L.; Fiscon, G.; Marchetti, P.; Fabi, A.; Botticelli, A. | |
| Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC. Report of two cases | 2024 | Siringo, M; Larocca, F; Spagnuolo, A; Gentile, G; Anile, M; Diso, D; Santini, D; Gelibter, A | |
| Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study | 2023 | Siringo, Marco; Gentile, Gabriella; Caponnetto, Salvatore; Sperduti, Isabella; Santini, Daniele; Cortesi, Enrico; Gelibter, ALAIN JONATHAN | |
| FBXW7 Gene Mutation and Expression in Colorectal Cancer (CRC): A Systematic Review from Molecular Mechanisms to Clinical Translation | 2025 | Arrivi, Giulia; Gentile, Gabriella; Roberto, Michela; Delle Cave, Donatella | |
| Fertility preservation in young patients with breast cancer: insights from the Gemme Dormienti network | 2025 | Gentile, Gabriella; Tesei, Cristiano; Brunetti, Stefania; Cavaceppi, Paola; Sorrenti, Giuseppe; Lambertini, Matteo; Ciccarone, Mariavita | |
| Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies | 2025 | Arecco, Luca; De Moura Leite, Luciana; Gentile, Gabriella; Jankovic, Kristina; Stana, Mihaela; Ottonello, Silvia; Scavone, Graziana; Spinaci, Stefano; Lambertini, Matteo | |
| Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives | 2025 | Arecco, Luca; Gentile, Gabriella; Gerosa, Riccardo; Lambertini, Matteo; Buisseret, Laurence; De Caluwé, Alex; De Azambuja, Evandro | |
| Management of fertility preservation in young female patients with gastrointestinal cancer: A case series and systematic literature review | 2025 | Gentile, Gabriella; Ciccarone, Mariavita | |
| Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge | 2025 | Gerosa, R.; Gentile, G.; Arecco, L.; Dauccia, C.; Nannini, S.; Lobo-Martins, S.; Agostinetto, E.; Lambertini, M.; Santoro, A.; Aftimos, P.; Piccart-Gebhart, M.; De Azambuja., E. | |
| Out-of-pocket costs burden for cancer treatment toxicities and symptoms management in Italy: A prospective, multicenter pilot study | 2023 | Giusti, Raffaele; Filetti, Marco; Lombardi, Pasquale; Gentile, Gabriella; Toccaceli, Paolo; Fumi, Guglielmo; Vacca, Denise; Colpani, Emilia; Ravoni, Giulio; Daniele, Gennaro; Porzio, Giampiero | |
| Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis | 2023 | Arecco, L; Blondeaux, E; Bruzzone, M; M Latocca, M; Mariamidze, E; Begijanashvili, S; Sokolovic, E; Gentile, G; Scavone, G; Ottonello, S; Boutros, A; Vaz-Luis, I; Saura, C; A Anderson, R; Demeestere, I; A Azim Jr, H; de Azambuja, E; A Peccatori, F; Del Mastro, L; H Partridge, A; Lambertini, M | |
| Selective Internal Radiation Therapy (SIRT): a new emerging role for Breast Cancer Liver Metastases | 2023 | Gentile, G; Salvatori, F; Siringo, M; Cianni, R; Bagni, O; Caponnetto, S; Cortesi, E | |
| The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a sub-analysis of the APHINITY trial | 2026 | Agostinetto, Elisa; Gentile, Gabriella; Samy, Faye; Di Cosimo, Serena; Aftimos, Philippe; Pondé, Noam; Eiger, Daniel; Lambertini, Matteo; Cameron, David; Kiermaier, Astrid; Bailey, Andrew; Viale, Giuseppe; Loi, Sherene; Piccart, Martine; De Azambuja, Evandro | |
| The efficacy of preoperative low-residue diet on postoperative ileus following cesarean section | 2023 | Palaia, I.; Caruso, G.; Perniola, G.; Di Donato, V.; Brunelli, R.; Vestri, A.; Scudo, M.; Gentile, G.; Musella, A.; Benedetti Panici, P.; Muzii, L. | |
| The financial toll of cancer: uncovering the links between financial toxicity and symptom burden | 2025 | Filetti, Marco; Lombardi, Pasquale; Gentile, Gabriella; Toccaceli, Paolo; Fumi, Guglielmo; Vacca, Denise; Colpani, Emilia; Ravoni, Giulio; Mazzuca, Federica; Daniele, Gennaro; Porzio, Giampiero; Bruera, Eduardo; Giusti, Raffaele |